These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2380544)

  • 1. Factors associated with relapse during maintenance treatment of affective disorders.
    Leverich GS; Post RM; Rosoff AS
    Int Clin Psychopharmacol; 1990 Apr; 5(2):135-56. PubMed ID: 2380544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine in rapid cycling bipolar affective disorder.
    Joyce PR
    Int Clin Psychopharmacol; 1988 Apr; 3(2):123-9. PubMed ID: 3397520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium prophylaxis of bipolar illness. The value of combination treatment.
    Peselow ED; Fieve RR; Difiglia C; Sanfilipo MP
    Br J Psychiatry; 1994 Feb; 164(2):208-14. PubMed ID: 7909713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine in the prophylaxis of mood disorders.
    Stuppaeck C; Barnas C; Miller C; Schwitzer J; Fleischhacker WW
    J Clin Psychopharmacol; 1990 Feb; 10(1):39-42. PubMed ID: 2307735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of carbamazepine and lithium on affective disorders.
    Okuma T
    Neuropsychobiology; 1993; 27(3):138-45. PubMed ID: 8232828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium-carbamazepine versus lithium-neuroleptic prophylaxis in bipolar illness.
    Shukla S; Cook BL; Miller MG
    J Affect Disord; 1985 Nov; 9(3):219-22. PubMed ID: 2867109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.
    Fawcett J; Kravitz HM
    J Clin Psychiatry; 1985 Feb; 46(2):58-60. PubMed ID: 3968046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder?
    Kleindienst N; Greil W
    J Clin Psychiatry; 2004 Jul; 65(7):966-74. PubMed ID: 15291686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.
    Denicoff KD; Smith-Jackson EE; Disney ER; Ali SO; Leverich GS; Post RM
    J Clin Psychiatry; 1997 Nov; 58(11):470-8. PubMed ID: 9413412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse.
    Harvey NS; Kay R
    J Clin Psychopharmacol; 1991 Dec; 11(6):362-7. PubMed ID: 1770155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine in manic-depressive illness: a new treatment.
    Ballenger JC; Post RM
    Am J Psychiatry; 1980 Jul; 137(7):782-90. PubMed ID: 7386656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients.
    Baethge C; Baldessarini RJ; Mathiske-Schmidt K; Hennen J; Berghöfer A; Müller-Oerlinghausen B; Bschor T; Adli M; Bauer M
    J Clin Psychiatry; 2005 Feb; 66(2):174-82. PubMed ID: 15705002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.
    Kleindienst N; Greil W
    Neuropsychobiology; 2000; 42 Suppl 1():2-10. PubMed ID: 11093063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of affective disorder with carbamazepine: prophylactic synergism of lithium and carbamazepine combination.
    Kishimoto A
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):483-93. PubMed ID: 1641493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot antipsychotics in bipolar affective disorder.
    White E; Cheung P; Silverstone T
    Int Clin Psychopharmacol; 1993; 8(2):119-22. PubMed ID: 8102150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes.
    Ketter TA; Houston JP; Adams DH; Risser RC; Meyers AL; Williamson DJ; Tohen M
    J Clin Psychiatry; 2006 Jan; 67(1):95-101. PubMed ID: 16426094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term follow-up.
    Post RM; Leverich GS; Rosoff AS; Altshuler LL
    J Clin Psychopharmacol; 1990 Oct; 10(5):318-27. PubMed ID: 2124216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic and prophylactic effects of carbamazepine in bipolar disorders.
    Okuma T
    Psychiatr Clin North Am; 1983 Mar; 6(1):157-74. PubMed ID: 6351033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.